Product Name : Etoricoxib
Grade : IP / BP / USP
Therapeutic Category : NSAID
CAS No : 202409-33-4
Etoricoxib (Arcoxia) is a selective COX-2 inhibitor. Etoricoxib is indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain, and gout.
The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:
Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.
Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.
North & South America: USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela , Brazil, Bahamas, Ecuador, etc .
Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.
OCEANIA: Australia, New Zealand, Fiji, etc.
Etoricoxib Manufacturers India, Etoricoxib suppliers India, Etoricoxib Exporters India, Etoricoxib Powder Manufacturer India, Etoricoxib Powder Supplier India, Etoricoxib API Manufacturer India, Etoricoxib API Suppliers India, Buy Etoricoxib Online India, Etoricoxib Price, Etoricoxib Bulk Drugs Manufacturer India, Etoricoxib